» Articles » PMID: 23801097

Beyond Weight Loss: a Review of the Therapeutic Uses of Very-low-carbohydrate (ketogenic) Diets

Overview
Journal Eur J Clin Nutr
Date 2013 Jun 27
PMID 23801097
Citations 311
Authors
Affiliations
Soon will be listed here.
Abstract

Very-low-carbohydrate diets or ketogenic diets have been in use since the 1920s as a therapy for epilepsy and can, in some cases, completely remove the need for medication. From the 1960s onwards they have become widely known as one of the most common methods for obesity treatment. Recent work over the last decade or so has provided evidence of the therapeutic potential of ketogenic diets in many pathological conditions, such as diabetes, polycystic ovary syndrome, acne, neurological diseases, cancer and the amelioration of respiratory and cardiovascular disease risk factors. The possibility that modifying food intake can be useful for reducing or eliminating pharmaceutical methods of treatment, which are often lifelong with significant side effects, calls for serious investigation. This review revisits the meaning of physiological ketosis in the light of this evidence and considers possible mechanisms for the therapeutic actions of the ketogenic diet on different diseases. The present review also questions whether there are still some preconceived ideas about ketogenic diets, which may be presenting unnecessary barriers to their use as therapeutic tools in the physician's hand.

Citing Articles

The Influence of Physical Exercise, Ketogenic Diet, and Time-Restricted Eating on De Novo Lipogenesis: A Narrative Review.

Paoli A Nutrients. 2025; 17(4).

PMID: 40004991 PMC: 11858292. DOI: 10.3390/nu17040663.


Roadmap for alleviating the manifestations of ageing in the cardiovascular system.

Liberale L, Tual-Chalot S, Sedej S, Ministrini S, Georgiopoulos G, Grunewald M Nat Rev Cardiol. 2025; .

PMID: 39972009 DOI: 10.1038/s41569-025-01130-5.


Very Low Energy Ketogenic Therapy (VLEKT), Not Only a Price Matter: A Comparison Study on Average Costs of VLEKT with Fresh Foods and Replacement Meals.

Annunziata G, Verde L, Falco A, Savastano S, Colao A, Muscogiuri G Nutrients. 2025; 17(3).

PMID: 39940282 PMC: 11821162. DOI: 10.3390/nu17030422.


A ketogenic diet regulates microglial activation to treat drug addiction.

Ji J, Tang Y Front Pharmacol. 2025; 16:1462699.

PMID: 39917617 PMC: 11799558. DOI: 10.3389/fphar.2025.1462699.


Effect of a Ketogenic Diet on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Progression: A Randomized Controlled Trial.

Chirapongsathorn S, Rintaravitoon W, Tangjaturonrasme B, Chotsriluecha S, Pumsutas Y, Kanchanapradith A JGH Open. 2025; 9(1):e70099.

PMID: 39834906 PMC: 11743996. DOI: 10.1002/jgh3.70099.


References
1.
Warburg O, Wind F, Negelein E . THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol. 2009; 8(6):519-30. PMC: 2140820. DOI: 10.1085/jgp.8.6.519. View

2.
Klement R, Kammerer U . Is there a role for carbohydrate restriction in the treatment and prevention of cancer?. Nutr Metab (Lond). 2011; 8:75. PMC: 3267662. DOI: 10.1186/1743-7075-8-75. View

3.
Henderson S, Vogel J, Barr L, Garvin F, Jones J, Costantini L . Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond). 2009; 6:31. PMC: 2731764. DOI: 10.1186/1743-7075-6-31. View

4.
Dashti H, Al-Zaid N, Mathew T, Al-Mousawi M, Talib H, Asfar S . Long term effects of ketogenic diet in obese subjects with high cholesterol level. Mol Cell Biochem. 2006; 286(1-2):1-9. DOI: 10.1007/s11010-005-9001-x. View

5.
Barrett-Connor E . Sex hormone-binding globulin and glucose tolerance in postmenopausal women. The Rancho Bernardo Study. Diabetes Care. 1997; 20(4):645-9. DOI: 10.2337/diacare.20.4.645. View